ABSTRACT
We report two isothermal nucleic acid amplification assays for detection of monkeypox virus (MPXV) clades 2 and 3 that include the strains responsible for the current global outbreak of monkeypox. The assays use loop-mediated isothermal amplification (LAMP) to amplify two distinct sequences in the MPXV genome. Readout specificity is ensured by oligonucleotide strand displacement (OSD) probes integrated in one-pot LAMP-OSD reactions. OSD probes undergo toehold-mediated strand displacement hybridization to LAMP amplicon loop sequences derived from MPXV clades 2 and 3 resulting in fluorescence readable both in realtime and visually at endpoint. We also perform both assays on two different portable devices, the GeneTiger and the miniPCR, to exemplify compatibility with minimum infrastructure point-of-care (POC) testing in clinical and at-home settings. Both assays could readily detect single digit copies of MPXV synthetic double stranded DNA templates within 30 min.
Competing Interest Statement
SB and ADE are named inventors on US patent US20160076083A1 covering LAMP-OSD assigned to the University of Texas System.
Funding Statement
This work was supported by the Welch Foundation (F-1654) and the National Institutes of Health (1R01EB027202-01A1 and 3R01EB027202-01A1S1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Emails: SB: sanchitabhadra{at}utexas.edu; ADE: ellingtonlab{at}gmail.com
Data Availability
All data in the present work and contained in the manuscript.
